G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 113 filers reported holding G1 THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $4,121,000 | -61.6% | 542,183 | -48.4% | 0.32% | -52.8% |
| Q4 2021 | $10,720,000 | -16.9% | 1,049,947 | +9.2% | 0.68% | -14.6% |
| Q3 2021 | $12,898,000 | -27.9% | 961,139 | +17.9% | 0.80% | -11.7% |
| Q2 2021 | $17,888,000 | +23.6% | 815,316 | +35.5% | 0.91% | -5.5% |
| Q1 2021 | $14,474,000 | – | 601,591 | – | 0.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 994,287 | $19,041,000 | 1.55% |
| HHLR ADVISORS, LTD. | 949,431 | $18,182,000 | 0.75% |
| BB BIOTECH AG | 671,925 | $12,867,000 | 0.41% |
| Rhenman & Partners Asset Management AB | 172,820 | $3,310,000 | 0.38% |
| Birchview Capital, LP | 15,000 | $287,000 | 0.27% |
| Rock Springs Capital Management LP | 100,000 | $1,915,000 | 0.09% |
| SECOR Capital Advisors, LP | 32,591 | $624,000 | 0.08% |
| MARSHALL WACE, LLP | 386,510 | $7,402,000 | 0.08% |
| SIGNATUREFD, LLC | 37,942 | $727,000 | 0.07% |
| A.R.T. Advisors, LLC | 38,125 | $730,000 | 0.05% |